State NH
Clinical Trials in New Hampshire
Recruiting clinical trials with at least one study location in New Hampshire. Data updated daily from ClinicalTrials.gov.
Top Conditions in New Hampshire
Malignant Solid Neoplasm (2)Cognitive Dysfunction (2)Memory Disorders (2)Memory Impairment (2)Memory Dysfunction (2)Acute Myeloid Leukemia (2)Chronic Lymphocytic Leukemia (2)Adrenal Gland Pheochromocytoma (1)Carcinoma In Situ (1)Central Nervous System Neoplasm (1)Childhood Immature Teratoma (1)Childhood Kidney Neoplasm (1)
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06569537 Phase 4
Recruiting
Comparison of Compounded Topical Anesthetics
Condition
Procedural Pain
Enrollment
64 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT05900895 Phase 1
Recruiting
Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
Condition
Metastatic Breast Cancer
Enrollment
6 pts
Location
United States
Sponsor
Mary D Chamberlin
NCT06951919 N/A
Recruiting
HOBSCOTCH-MS-Efficacy Trial
Condition
Multiple Sclerosis
Enrollment
125 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT06810518 N/A
Recruiting
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stoo...
Condition
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
Enrollment
220 pts
Location
United States
Sponsor
American Laboratory Products C
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
NCT06429280 N/A
Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
Condition
Amblyopia
Enrollment
500 pts
Location
United States
Sponsor
Luminopia
NCT06029660 N/A
Recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of...
Condition
Aortic Aneurysm, Abdominal
Enrollment
180 pts
Location
United States, France, Netherlands
Sponsor
Shape Memory Medical, Inc.
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
NCT06997029 Phase 1
Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced ...
Condition
Advanced Solid Tumor
Enrollment
234 pts
Location
United States, Denmark, Japan
Sponsor
Bristol-Myers Squibb
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT04600973 N/A
Recruiting
Improving Implementation of Evidence-based Approaches and Surveillance to Preven...
Condition
Infection
Enrollment
6,000 pts
Location
United States
Sponsor
Trustees of Dartmouth College
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT04552275 Phase 1
Recruiting
The HALT Biomarker Study
Condition
Aortic Stenosis
Enrollment
300 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT05230173 N/A
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remi...
Condition
Ulcerative Colitis
Enrollment
250 pts
Location
United States
Sponsor
University of California, San
NCT06986122 N/A
Recruiting
Virtual Contexts for Affective Modulation
Condition
Pain Control
Enrollment
20 pts
Location
United States
Sponsor
Trustees of Dartmouth College
NCT07041151 N/A
Recruiting
Self-discontinuation of Urinary Catheters in a Rural Population
Condition
Post-Operative Urinary Retention
Enrollment
100 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT05243797 Phase 3
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Al...
Condition
Multiple Myeloma
Enrollment
1,594 pts
Location
United States, Argentina, Australia
Sponsor
European Myeloma Network B.V.
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT06149286 Phase 3
Recruiting
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works...
Condition
Relapsed/Refractory Follicular Lymphoma
Enrollment
470 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
Page 1 of 2 — 49 trials total